Date published: 2026-1-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

PDE6α Activators

PDE6α Activators encompass a range of chemical compounds that indirectly augment the functional activity of PDE6α, primarily through the modulation of cyclic nucleotide levels within cells. Sildenafil, Tadalafil, Vardenafil, Hydrochloride Salt, and Zaprinast (M&B 22948) function as selective inhibitors of phosphodiesterase type 5 (PDE5), leading to an elevation in cyclic guanosine monophosphate (cGMP) levels. This rise in cGMP indirectly enhances PDE6α activity, which is crucial in the phototransduction process in retinal cells. These compounds ensure that cGMP, a substrate of PDE6α, is abundantly available, thereby facilitating the role of PDE6α in the visual cycle. Similarly, Ibudilast and Rolipram, through their inhibition of PDE4, may also contribute to increased cGMP levels, indirectly supporting PDE6α's function in the retina. These compounds, while primarily increasing cyclic adenosine monophosphate (cAMP), can have a secondary effect on cGMP concentrations, thus influencing PDE6α activity.

Further, compounds like Anagrelide, Milrinone, and Cilostazol, which inhibit PDE3, may indirectly raise cGMP levels, enhancing PDE6α's role in phototransduction. Their primary action on cAMP levels has a cascading effect that can benefit cGMP dynamics, indirectly supporting PDE6α activity. Dipyridamole, with its inhibitory effect on both PDE5 and PDE6, ensures an increase in cGMP levels, thus indirectly promoting PDE6α's functionality. This mechanism is particularly significant in the retina, where PDE6α plays a pivotal role. Additionally, Theophylline and Pentoxifylline, as non-selective PDE inhibitors, contribute to the increased availability of cGMP. By inhibiting a broad range of phosphodiesterases, these compounds elevate cGMP levels, indirectly fostering an environment conducive to enhanced PDE6α activity. Collectively, these PDE6α Activators, by increasing cGMP levels through various mechanisms, indirectly facilitate the enhancement of PDE6α-mediated functions crucial for vision, particularly in the context of phototransduction in retinal cells.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tadalafil

171596-29-5sc-208412
50 mg
$180.00
13
(2)

Tadalafil, by inhibiting PDE5, leads to increased cGMP levels, similar to Sildenafil. This cGMP elevation indirectly enhances PDE6α activity in retinal photoreceptors.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$526.00
$735.00
$16653.00
7
(1)

Vardenafil, Hydrochloride Salt's inhibition of PDE5 results in raised cGMP concentrations, indirectly enhancing PDE6α activity, thereby affecting phototransduction in the retina.

Ibudilast

50847-11-5sc-203080
10 mg
$218.00
1
(1)

Ibudilast inhibits PDE4 and PDE10A but also increases cGMP levels indirectly, thereby potentially enhancing PDE6α activity in retinal photoreceptors.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram, by inhibiting PDE4, indirectly leads to increased cAMP and possibly cGMP levels, thereby potentially enhancing PDE6α activity in the retina.

Anagrelide

68475-42-3sc-491875
25 mg
$150.00
(0)

Anagrelide, a PDE3 inhibitor, may indirectly increase cGMP levels, which could enhance PDE6α activity in the phototransduction process.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$165.00
$697.00
7
(0)

Milrinone, a PDE3 inhibitor, can indirectly lead to elevated cGMP levels, potentially enhancing PDE6α activity in the retina.

Cilostazol

73963-72-1sc-201182
sc-201182A
10 mg
50 mg
$109.00
$322.00
3
(1)

Cilostazol inhibits PDE3 and increases cAMP levels, which may indirectly influence cGMP levels and enhance PDE6α activity in retinal photoreceptors.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$31.00
$102.00
1
(1)

Dipyridamole, by inhibiting PDE5 and PDE6, can lead to increased cGMP levels, indirectly promoting PDE6α activity, especially in the retina.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Theophylline, a non-selective PDE inhibitor, may raise cGMP levels indirectly, enhancing PDE6α activity in the phototransduction pathway.

Pentoxifylline

6493-05-6sc-203184
1 g
$20.00
3
(1)

Pentoxifylline, by inhibiting various PDEs, can increase cGMP levels, which indirectly could enhance PDE6α activity in the retina.